HAS Healthcare Advanced Synthesis offers a full range of customized services for our clients – from lab development, to manufacturing, to regulatory and approval and beyond, specializing in high potency substances.
We develop and manufacture Active Pharmaceutical Ingredients (APIs), cGMP Advanced Intermediates, High Potency APIs (HPAPIs) and Anticancer compounds for our clients from clinical to commercial supply, on an exclusive basis.
At HAS Healthcare Advanced Synthesis we’re passionate about tailoring our services to our clients’ clinical and commercial manufacturing needs and going the extra mile to support them with their analytical and regulatory requirements. We specialize in the delivery of oncology and rare disease compounds and hold a strong track record in reducing time to market for life saving products in these areas.
Via Industria 24
|T.: +41 91 873 94 00|
|F.: +41 91 873 01 11|
Main activities Co-development ● Drug Substance CMO ● Other CMO Activities ●
Drug stages Phase I - Phase III ● Registration ● Market ● Generic ● Life cycle management ●
Therapeutic areas Cancer supportive therapy ● CNS ● Dermatology ● Gastrointestinal ● Gynaecology ● Oncology ● Ophtalmology ● Respiratory ● Other ●
Markets CH ● EU Top 5 ● Rest of Europe ● USA and Canada ● LATAM ● Japan ●
Drug substance type APIs (1-10kgs/batch) ● APIs (20-200kgs/batch) ● APIs (>200kgs/batch) ● HPAI 10-100g/batch ● HPAI 0.2-5kgs/batch ● HPAI 6-20kgs/batch ● HPAI >20kgs/batch ● HPAI Cat. 3 safebridge ● Cytotoxics ●
Other CMO activities Micronization ●